Root (NASDAQ:ROOT) reported second-quarter 2026 net income of $25 million, up 15% from a year earlier, as the auto insurer emphasized underwriting discipline and continued investment in technology, distribution and geographic expansion.
Revenue rose 2% year over year to $389 million, while policies
Sunrun (NASDAQ:RUN) reported second-quarter results marked by a record storage attachment rate, positive cash generation excluding safe-harbor equipment investments, and a reduced full-year outlook as the company shifts toward a larger direct-sales business.
Chief Executive Officer Mary Powell said
Revolution Medicines (NASDAQ:RVMD) said its second-quarter 2026 results reflected continued investment in late-stage cancer programs, commercial launch preparations and manufacturing capacity as it advances daraxonrasib and other RAS-targeted therapies across pancreatic and lung cancer.
The company
Power Integrations (NASDAQ:POWI) reported second-quarter revenue of $118.9 million, up 10% sequentially and 3% from a year earlier, as all four of its end-market categories improved from the prior quarter. The company also expanded non-GAAP operating margin to 17.1% and generated $22 million in oper
Portillo's (NASDAQ:PTLO) reported second-quarter revenue growth of 5.6% to $199 million, supported by new restaurant openings, while same-restaurant sales declined 1.2% amid comparisons with prior-year promotions, a breakfast pilot and cannibalization from newer locations.
President and Chief Execu
Pattern Group (NASDAQ:PTRN) reported record second-quarter results, with revenue rising 47% year over year to $877 million and adjusted EBITDA increasing 54% to $54 million. Chief Executive Officer Dave Wright said the company’s adjusted EBITDA growth exceeded revenue growth for the fourth consecuti
Remitly Global (NASDAQ:RELY) reported second-quarter results above its guidance range, with revenue rising 20% year over year to $495 million and adjusted EBITDA reaching a record $115 million, or a 23% margin.
Chief Executive Officer Sebastian Gunningham said the company also surpassed 10 million
OraSure Technologies (NASDAQ:OSUR) reported second-quarter revenue of $30.6 million, exceeding its guidance range and rising 9.7% sequentially, as stronger public-health diagnostics demand and growth in sample-management products supported results.
President and Chief Executive Officer Carrie Eglin
Pacific Biosciences of California (NASDAQ:PACB) reported second-quarter 2026 revenue of $39 million, roughly flat from $39.8 million a year earlier, while announcing an immediate leadership transition and lowering its full-year revenue outlook amid a slower-than-expected rollout of its new multi-use
Paysign (NASDAQ:PAYS) reported record second-quarter revenue, net income and adjusted EBITDA for 2026, driven primarily by continued expansion in its Patient Affordability business and improving utilization in its plasma donor compensation operations.
Revenue rose 48.1% from a year earlier to $28.3
News (NASDAQ:NWS) reported record fourth-quarter profitability for fiscal 2026, with revenue rising 11% year over year to $2.3 billion and total segment EBITDA increasing 31% to $423 million. Net income from continuing operations climbed 167% to $230 million, while reported earnings per share rose t
Nyxoah (NASDAQ:NYXH) reported second-quarter worldwide net revenue of €7.7 million, up 21% sequentially from the first quarter, as its U.S. commercial launch continued to expand. U.S. net revenue reached €5.2 million, a 22% increase from the prior quarter, while international revenue rose 19% sequen
Oportun Financial (NASDAQ:OPRT) reported second-quarter 2026 results that exceeded its guidance ranges, supported by modest origination growth, lower credit losses and reduced interest expense. The company also raised its full-year adjusted EBITDA outlook and lowered its expected annualized net char
Magnite (NASDAQ:MGNI) reported second-quarter results that exceeded its expectations, driven by continued growth in connected television and a return to growth in its DV+ business. The company raised its full-year outlook for Contribution ex-TAC, Adjusted EBITDA growth, margin expansion and free cas
Mirum Pharmaceuticals (NASDAQ:MIRM) reported second-quarter net product sales of $176 million and raised its full-year 2026 product sales outlook to $680 million to $700 million, while outlining several upcoming clinical and regulatory milestones across its rare liver and rare genetic disease portfo
MannKind (NASDAQ:MNKD) reported second-quarter revenue of $109.4 million, up 43% from the prior-year period, as growth in its commercial products and collaboration revenue helped offset increased spending tied to product launches and development programs.
The company recorded a GAAP net loss of $19
Everspin Tech (NASDAQ:MRAM) reported record second-quarter revenue as growth in MRAM product sales and initial revenue from a new U.S. defense-related subcontract lifted results above the company’s guidance range.
For the quarter ended June 30, 2026, Everspin posted revenue of $18.7 million, up 42%
MercadoLibre (NASDAQ:MELI) reported second-quarter 2026 net revenue of more than $10 billion for the first time, representing 50% year-over-year growth, while the company continued to emphasize investments in commerce, fintech, logistics and artificial intelligence over near-term margin expansion.
